, Volume 16, Issue 3, pp 227–240 | Cite as

Pharmacological investigation of the role of leukotrienes in the pathogenesis of experimental NSAID gastropathy

  • Paula M. Vaananen
  • Catherine M. Keenan
  • Matthew B. Grisham
  • John L. Wallace
Original Articles


The role of leukotrienes in the pathogenesis of acute gastric ulceration induced by nonsteroidal antiinflammatory drugs was investigated using a rat model. One part of the study involved oral pretreatment with a leukotriene synthesis inhibitor 1 h prior to administration of indomethacin (20 mg/kg per os). Three hours after indomethacin, the extent of macroscopically visible gastric damage was determined, and gastric LTB4 synthesis was determined. The compounds tested were PF-5901, A-64077, nordihydroguaiaretic acid, and L-698,037. Each compound produced dose-related inhibition of gastric LTB4 synthesis and a parallel reduction in the severity of indomethacin-inducec damage. The antioxidant properties of these compounds was assessed using an in vitro assay. There was no correlation between the antioxidant properties of the compounds and their ability to reduce the severity of indomethacin-induced gastric damage. In the second part of the study, the effects of intravenous administration of LTD4 and LTB4 receptor antagonists on indomethacin-induced gastric epithelial damage (measured by permeability to [51Cr]EDTA) were assessed. The two LTD4 receptor antagonists (MK-571 and ICI-204,219) significantly reduced the permeability changes induced by indomethacin, while the two LTB4 antagonists (SC-41930 and LY-255,283) were without significant effect. Despite the reduction of gastric epithelial injury, blockade of LTD4 receptors did not markedly affect the extent of macroscopically visibls injury. These data are consistent with the hypothesis that leukotrienes contribute to the epithelial injury and macroscopically visible damage induced by NSAIDs. However, it remains unclear to what extent leukotrienes are involved in the initiation of the injury, as opposed to its amplification.


Indomethacin LTB4 Epithelial Injury Epithelial Damage Gastric Damage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rainsford, K. D., andC. Willis. 1982. Relationship of gastric mucosal damage induced in pigs by antiinflammatory drugs to their effects on prostaglandin production.Dig. Dis. Sci. 27:624–635.Google Scholar
  2. 2.
    Whittle, B. J. R. 1981. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat.Gastroenterology 80:94–98.Google Scholar
  3. 3.
    Rainsford, K. D. 1987. The effects of 5-lipoxygenase inhibitors and leukotriene antagonists on the development of gastric lesions induced by nonsteroidal antiinflammatory drugs in mice.Agents Actions 21:316–319.Google Scholar
  4. 4.
    Peskar, B. 1991. Role of leukotriene C4 in mucosal damage caused by necrotizing agents and indomethacin in the rat stomach.Gastroenterology 100:619–626.Google Scholar
  5. 5.
    Bjarnason, I., andT. J. Peters. 1989. Intestinal permeability, non-steroidal anti-inflammatory drug enteropathy and inflammatory bowel disease: An overview.Gut 30:22–28.Google Scholar
  6. 6.
    Trautmann, M., B. M. Peskar, andB. A. Peskar. 1991. Aspirin-like drugs, ethanol-induced rat gastric injury and mucosal eicosanoid release.Eur. J. Pharmacol. 201:53–58.Google Scholar
  7. 7.
    Wallace, J. L., C. M. Keenan, D. Gale, andT. S. Shoupe. 1992. Exacerbation of experimental colitis by nonsteroidal antiinflammatory drugs is not related to elevated leukotriene B4 synthesis.Gastroenterology 101:18–27.Google Scholar
  8. 8.
    Konturek, S. J., T. Brzozowski, D. Drozdowicz, andG. Beck. 1988. Role of leukotrienes in acute gastric lesions induced by ethanol, taurocholate, aspirin, platelet-activating factor and stress in rats.Dig. Dis. Sci. 33:806–813.Google Scholar
  9. 9.
    Pihan, G., C. Rogers, andS. Szabo. 1988. Vascular injury in acute gastric mucosal damage: Mediatory role in leukotrienes.Dig. Dis. Sci. 33:625–632.Google Scholar
  10. 10.
    Wallace, J. L., G. W. McKnight, C. M. Keenan, N. I. A. Byles, andW. K. MacNaughton. 1990. Effects of leukotrienes on susceptibility of the rat stomach to damage and investigation of the mechanism of action.Gastroenterology 98:1178–1186.Google Scholar
  11. 11.
    Wallace, J. L., andG. W. McKnight. 1990. Comparison of the damage-promoting effects of leukotrienes derived from eicosapentaenoic acid and arachidonic acid on the rat stomach.J. Exp. Med. 171:1827–1832.Google Scholar
  12. 12.
    Peskar, B. M. 1988. Role of leukotrienes in gastric mucosal damage and protection.In Prostaglandins and Leukotrienes in Gastrointestinal Diseases. W. Domschke and H. G. Dammann, editors. Springer-Verlag, Berlin. 81–87.Google Scholar
  13. 13.
    Wallace, J. L., andB. J. R. Whittle. 1985. Role of prostanoids in the protective actions of BW755C on the gastric roucosa.Eur. J. Pharmacol. 115:45–52.Google Scholar
  14. 14.
    Nielsen, S. T., L. Beninati, andJ. Chang. 1987. REV 5901 and Ly 171,883 protect rat gastric mucosa against ethanol-induced damage.Agents Actions 21:320–322.Google Scholar
  15. 15.
    Whittle, B. J. R., N. Oren-Wolman, andP. H. Guth. 1985. Gastric vasoconstrictor actions of leukotriene C4, PGF2a, and thromboxane mimetic U-46619 on rat submucosal microcirculation in vivo.Am. J. Physiol. 248:G580-G586.Google Scholar
  16. 16.
    Bray, M. A. 1983. The pharmacology and pathophysiology of leukotriene B4.Br. Med. Bull. 39:249–254.Google Scholar
  17. 17.
    Wallace, J. L., C. M. Keenan, andD. N. Granger. 1990. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process.Am. J. Physiol. 259:G462-G467.Google Scholar
  18. 18.
    Wallace, J. L., K.-E. Arfors, andG. W. McKnight. 1991. A monoclonal antibody against the CD18 leukocyte adhesion molecule prevents indomethacin-induced gastric damage in the rabbit.Gastroenterology 100:878–883.Google Scholar
  19. 19.
    Vaananen, P. M., J. B. Meddings, andJ. L. Wallace. 1991. Role of oxygen-derived free radicals in indomethacin-induced gastric injury.Am. J. Physiol. 261:G470-G475.Google Scholar
  20. 20.
    Kitahora, T., andP. H. Guth. 1987. Effect of aspirin plus hydrochloric acid on the gastric mucosal microcirculationGastroenterology 93:810–817.Google Scholar
  21. 21.
    Hudson, N., S. Everitt, T. Edwards, B. Filopowicz, andC. J. Hawkey. 1991. Elevation of gastric mucosal leukotriene B4 levels in patients on longstanding NSAID therapy.Gastroenterology 100:A86 (abstract).Google Scholar
  22. 22.
    Laursen, L. S., J. Naesoal, K. Bukhave, K. Lauritsen, andJ. Rask-Madsen. 1990. Selective 5-lipoxygenase inhibition in ulcerative colitis.Lancet 0:683–685.Google Scholar
  23. 23.
    Kusner, E. J., R. L. Marks, D. Aharony, andR. D. Krell. 1989. Inhibition by REV-5901 of leukotriene release from guinea-pig and human lung tissue in vitro.Biochem. Pharmacol. 38:4183–4189.Google Scholar
  24. 24.
    Peskar, B. M., K. Lange, U. Hoppe, andB. A. Peskar. 1986. Ethanol stimulates formation of leukotriene C4 in rat gastric mucosa.Prostaglandins 31:283–293.Google Scholar
  25. 25.
    Wallace, J. L., P. L. Beck, andG. P. Morris. 1988. Is there a role for leukotrienes as mediators of ethanol-induced gastric mucosal damage.Am. J. Physiol. 254:G117-G123.Google Scholar
  26. 26.
    Pihan, G., C. Regillo, andS. Szabo. 1987. Free radicals and lipid peroxidation in ethanolor aspirin-induced gastric mucosal injury.Dig. Dis. Sci. 32:1395–1401.Google Scholar
  27. 27.
    Smith, R. C., J. Reeves, J. L. McKee, andH. Daron. 1987. Reaction of methylated urates with 1,1-diphenyl-2-picrylhydrazyl.Free Radical Biol. Med. 3:251–257.Google Scholar
  28. 28.
    Von Ritter, C., R. A. Hinder, M. M. J. Oosthuizen, L. G. Svensson, S. J. S. Hunter, andH. Lambrecht. 1988. Gastric mucosal lesions induced by hemorrhagic shock in baboons. Role of oxygen-derived free radicals.Dig. Dis. Sci. 33:857–864.Google Scholar
  29. 29.
    Wallace, J. L., C. M.Keenan, M.Cucala, K. G.Mugridge, and L.Parente. Mechanisms underlying the protective effects of interleukin-1 in experimental NSAID gastropathy.Gastroenterology (in press).Google Scholar
  30. 30.
    Wallace, J. L. 1987. Glucocorticoid-induced gastric mucosal damage: Inhibition of leukotriene, but not prostaglandin biosynthesis.Prostaglandins 34:311–323.Google Scholar
  31. 31.
    Jones, T. R., R. Zamboni, M. Belley, E. Champion, L. Charette, A. W. Ford-Hutchinson, R. Frenette, J.-Y. Gauthier, S. Leger, P. Masson, C. S. McFarlane, H. Piechuta, J. Rokach, R. N. Dehaven, andS. S. Pong. 1989. Pharmacology of L-660,711 (MK-571): A novel potent and selective leukotriene D4 receptor antagonist.Can. J. Physiol. Pharmacol. 67:17–28.Google Scholar
  32. 32.
    Djuric, S. W., P. W. Collins, P. H. Jones, R. L. Shone, B. S. Tsai, D. J. Fretland, G. M. Butchko, D. Villani-Price, R. H. Keith, J. M. Zemaitis, L. Metcalf, andR. F. Bauer. 1989. 7-[3-(4-Acetyl-3-methoxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-carboxylic acid: An orally active selective leukotriene B4 receptor antagonist.J. Med. Chem. 32:1145–1147.Google Scholar
  33. 33.
    Krell, R. D., D. Aharony, C. K. Buckner, R. A. Keith, E. J. Kusner, D. W. Snyder, P. R. Bernstein, V. G. Matassa, Y. K. Yee, F. J. Brown, B. Hesp, andR. E. Giles. 1990. The preclinical pharmacology of ICI 204,219.Am. Rev. Respir. Dis. 141:978–987.Google Scholar
  34. 34.
    Schultz, R. M., P. Marder, S. M. Spaethe, D. K. Herron, andM. J. Sofia. 1991. Effects of two leukotriene B4 (LTB4) receptor antagonists (LY255283 and SC-41930) on LTB4-induced human neutrophil adhesion and Superoxide production.Prostaglandins Leukotrienes Essent. Fatty Acids 43:267–271.Google Scholar
  35. 35.
    Villani-Price, D., D. C.Yang, D. J.Fretland, R. E.Walsh, R. H.Keith, G.Kocan, J. F.Kachur, T. S.Gaginella, and B. S.Tsai. 1990. Multiple actions of the leukotriene B4 receptor antagonist SC-41930.Proceedings, 5th Inflammation Research Association Conference 16 (abstract).Google Scholar
  36. 36.
    Gana, T. J., R. Huhlewych, andJ. Koo. 1987. Focal gastric mucosal blood flow in aspirininduced ulceration.Ann. Surg. 205:399–403.Google Scholar
  37. 37.
    Ashley, S. W., L. A. Sonnenschein, andL. Y. Cheung. 1985. Focal gastric mucosal blood flow at the site of aspirin-induced ulceration.Am. J. Surg. 149:53–59.Google Scholar
  38. 38.
    Wallace, J. L., andG. W. McKnight. 1990. The mucoid cap over superficial gastric damage in the rat. A high-pH microenvironment dissipated by nonsteroidal antiinflammatory drugs and endothelin.Gastroenterology 99:295–304.Google Scholar
  39. 39.
    Yonei, Y., andP. H. Guth. 1991. Ethanol-induced gastric injury. Role of submucosal venoconstriction and leukotrienes.Dig. Dis. Sci. 36:601–608.Google Scholar
  40. 40.
    Osada, T., H. Goto, Y. Tsukamoto, S. Nakazawa, S. Sugiyama, andT. Ozawa. 1990. Role of leukotrienes in hydrochloric acid-induced gastric lesions in rats.Dig. Dis. Sci. 35:186–192.Google Scholar
  41. 41.
    Mercer, D. W., R. Milner, S. O'Neill, W. P. Ritchie, Jr., andD. T. Dempsey. 1991. Leukotriene receptor blockade reduces bile acid-induced superficial gastric mucosal injury.J. Surg. Res. 50:602–608.Google Scholar
  42. 42.
    Boggs, J. M., C. H. Koo, andE. J. Goetzl. 1991. Down-regulation of receptor antigen in leukotriene B4-induced chemotactic deactivation of human polymorphonuclear leucocytes.Immunology 73:212–216.Google Scholar
  43. 43.
    Bouchelouche, P. N., andD. Berild. 1991. Possible existence of leukotriene D4 receptors and mechanism of their signal transduction in human polymorphonuclear leukocytes.Scand. J. Clin. Lab. Invest. 51(Suppl. 204):47–55.Google Scholar
  44. 44.
    Thomsen, M. K., andI. Ahnfelt-Ronne. 1989. Inhibition by the LTD4 antagonist, SR2640, of effects of LTD4 on canine polymorphonuclear leukocyte functions.Biochem. Pharmacol. 38:2291–2295.Google Scholar

Copyright information

© Plenum Publishing Corporation 1992

Authors and Affiliations

  • Paula M. Vaananen
    • 1
  • Catherine M. Keenan
    • 1
  • Matthew B. Grisham
    • 2
  • John L. Wallace
  1. 1.Gastrointestinal Research Group Faculty of MedicineUniversity of CalgaryCalgaryCanada
  2. 2.Department of Physiology and BiophysicsLSU Medical CenterShreveport

Personalised recommendations